New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 3, 2014
07:12 EDTXYL, HSCHarsco announces CEO Patrick Decker resigns, names David Everitt Interim CEO
Harsco (HSC) announced that Patrick K. Decker has stepped down as president and CEO and member of the board, effective immediately, to become CEO of Xylem (XYL). Harsco director David C. Everitt has been appointed Interim president and CEO and will continue as a member of the board. Everitt has served as a member of the board at Harsco since 2010 and brings significant senior executive experience to his new responsibilities.
News For HSC;XYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 20, 2015
07:18 EDTXYLXylem execution leads to growing constructive opinion at Canaccord
Canccord said they are clearly growing more constructive on Xylem following several quarters on the sidelines. The firm cited solid execution and operational initiatives that should prove beneficial this year, as well as bolt-on acquisition potential and the company's strong balance sheet. Canaccord maintains its Hold rating and $38 price target on Xylem shares.
July 16, 2015
09:14 EDTHSCHarsco CEO Nicholas Grasberger to assume leadership of Metals & Minerals segment
Subscribe for More Information
09:13 EDTHSCHarsco backs Q2 EPS 6c-12c, consensus 9c
Subscribe for More Information
July 14, 2015
12:59 EDTXYLGabelli says Xylem has 'big tailwind' over next three years
Subscribe for More Information
11:07 EDTXYLXylem shares advance after CFO resigns, preliminary Q2 results
Shares of global water technology provider Xylem are advancing after announcing the company CFO is resigning and also providing Q2 guidance last night. The company announced that Michael T. Speetzen, SVP and CFO, has resigned his position with the company to accept another CFO position, effective July 30. Shashank Patel will serve as interim CFO while the company conducts a search for a permanent successor. The company also provided a Q2 EPS view of 43c on revenue of $920M against average consensus estimates of 43c and $923.85M respectively. Shares of Xylem are up approximately 1% in late morning trading.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use